Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier.

Front Immunol · 2023 · PMC9981631 · PMID 36875096

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, these results did not reach statistical significance, likely due to small sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.